VIDEO: Fibrosis biomarkers show promise to replace liver biopsy
Publish date: October 23, 2017
By: Eli Zimmerman Frontline Medical News
WASHINGTON – The concentrations of three biomarkers successfully identified the severity of fibrosis in patients with nonalcoholic steatohepatitis (NASH), according to a study presented at the annual meeting of the American Association for the Study of Liver Diseases.
This noninvasive diagnostic method could replace liver biopsy, the current standard used to diagnose patients with NASH.
Read the article at
GI & Hepatology News
Links
View - "Video"
Conference Coverage
GI & Hepatology News
Navigate This Blog
The Liver Meeting® 2017Patient-Friendly Links
HCV Sites With Key Data, Expert Review & Summary
No comments:
Post a Comment